The US Food and Drug Administration (FDA) is the government agency that reviews animal medicines. The findings below come from its records and published research, checked in September 2026.
Approved for dogs?
No
Products sold online as GHK-Cu, KPV, BPC-157 or TB-500 hold no FDA approval, conditional approval or index listing for any animal.
That was the answer from FDA database searches run on September 30, 2026.
Conditional approval means a drug has passed checks on how it is made and whether it is safe, while full proof it works is still being gathered.
An index listing lets certain drugs be sold for animals such as ferrets and pet birds; this route excludes dogs.
From: Animal Drugs @ FDA and the FDA Index, searched September 30, 2026.
Tried on sick pet dogs?
Not found
PubMed is a collection of medical research papers. A search there on September 30, 2026 found no treatment trial of BPC-157 or TB-500 in sick or injured pet dogs.
That search did not cover every place research might appear.
The dog work that does exist used healthy lab beagles, to see how fast the body clears the peptide and whether it does harm.
From: PubMed searches and two lab beagle papers, read September 2026.
Anything about puppies?
A blank
The sources behind this page say nothing about peptides in puppies in particular.
No study of how a growing dog handles one turned up, so that gap belongs on the list of things to ask.
From: the same searches, which found no study of young dogs.
Who decides?
Your vet
Giving an approved medicine for a use absent from its label, such as another illness or another kind of animal, is called off-label use.
Only a licensed vet can decide on that use.
That route covers approved drugs only, so it cannot make an unapproved peptide a lawful pet medicine.
From: the federal rule on off-label animal drug use, read September 2026.